Search results
Another COVID vaccine? Yes, and here’s why
Denver Post· 2 days agovaccine has been shown to reduce the risk of having to go to the doctor with flu by 40% to 60%.” Last Wednesday, FDA’s advisers, a panel of physicians...
Here's To Science! Pfizer, Moderna Look To Combo Flu/COVID Vaccines
MediaPost· 3 days agoAlbert Bourla, Pfizer’s chief executive officer, acknowledged on Monday that, because the company’s stock price was down at the time, he gave the final sign-off on running ...
Pfizer Inc. (NYSE:PFE) Shares Sold by Cresset Asset Management LLC
ETF DAILY NEWS· 1 day agoCresset Asset Management LLC reduced its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent disclosure ...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 24 hours agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 24 hours agoMethylmalonic acidemia is a rare, genetic disease that prevents the body from breaking down proteins...
The FDA tells COVID-19 vaccine makers to update shot to target newest variant
KSL TV Utah· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
What is COVID KP.3 variant? Symptoms, CDC data, what to know about the newest COVID strain
USA Today· 2 days agoThe Centers for Disease Control and Prevention said it is tracking the new COVID variant KP.3 as data shows its dominance across the United States. For the two-week period starting on May 26 ...
Moderna says its combination COVID and flu vaccine tested better than separate shots
CBS News· 3 days agoModerna announced Monday that its combination COVID and flu vaccine showed positive results in a...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 5 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
